Terms: = Head and neck cancer AND HLA-A, P01892, 3105, ENSG00000206503, P16188, P30447, P13746, P04439
154 results:
1. Differentially Expressed Genes Involved in Primary Resistance to Immunotherapy in Patients with Advanced-Stage Pulmonary cancer.
Chinchilla-Tábora LM; Montero JC; Corchete LA; González-Morais I; Del Barco Morillo E; Olivares-Hernández A; Rodríguez González M; Sayagués JM; Ludeña MD
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396726
[TBL] [Abstract] [Full Text] [Related]
2. Leukocyte immunoglobulin-like receptor A3 gene deletion in five Chinese populations and protective association with nasopharyngeal carcinoma.
Tian W; Li LX; Cheng W; Jin HK; Zhang SS
Int J Immunogenet; 2024 Feb; 51(1):32-38. PubMed ID: 38015196
[TBL] [Abstract] [Full Text] [Related]
3. Proteogenomics Reveal the Overexpression of HLA-I in cancer.
Wang Y; Fenyö D
J Proteome Res; 2023 Nov; 22(11):3625-3639. PubMed ID: 37857377
[TBL] [Abstract] [Full Text] [Related]
4. Peptidome-wide association analysis of Epstein-Barr virus identifies epitope repertoires associated with nasopharyngeal carcinoma.
Deng CM; Wang TM; He YQ; Zhang WL; Xue WQ; Li DH; Yang DW; Wang QL; Liao Y; Diao H; Jiang CT; Zhang JB; Yuan LL; Chen XY; Zhou T; Li XZ; Zhang PF; Zheng XH; Zhang SD; Hu YZ; Xu M; Zeng MS; Feng L; Jia WH
J Med Virol; 2023 Jun; 95(6):e28860. PubMed ID: 37310118
[TBL] [Abstract] [Full Text] [Related]
5. Identification of HPV16 E1 and E2-specific T cells in the oropharyngeal cancer tumor microenvironment.
McInnis C; Bhatia S; Vijaykumar B; Tian Q; Sun Y; Leistritz-Edwards D; Quinn CT; Uppaluri R; Egloff AM; Srinivasan L; Pregibon DC; Coyle AJ; Hanna GJ
J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36990508
[TBL] [Abstract] [Full Text] [Related]
6. Autologous T cell therapy for MAGE-A4
Hong DS; Van Tine BA; Biswas S; McAlpine C; Johnson ML; Olszanski AJ; Clarke JM; Araujo D; Blumenschein GR; Kebriaei P; Lin Q; Tipping AJ; Sanderson JP; Wang R; Trivedi T; Annareddy T; Bai J; Rafail S; Sun A; Fernandes L; Navenot JM; Bushman FD; Everett JK; Karadeniz D; Broad R; Isabelle M; Naidoo R; Bath N; Betts G; Wolchinsky Z; Batrakou DG; Van Winkle E; Elefant E; Ghobadi A; Cashen A; Grand'Maison A; McCarthy P; Fracasso PM; Norry E; Williams D; Druta M; Liebner DA; Odunsi K; Butler MO
Nat Med; 2023 Jan; 29(1):104-114. PubMed ID: 36624315
[TBL] [Abstract] [Full Text] [Related]
7. Germline genetic biomarkers to stratify patients for personalized radiation treatment.
Deichaite I; Hopper A; Krockenberger L; Sears TJ; Sutton L; Ray X; Sharabi A; Navon A; Sanghvi P; Carter H; Moiseenko V
J Transl Med; 2022 Aug; 20(1):360. PubMed ID: 35962345
[TBL] [Abstract] [Full Text] [Related]
8. CRISPR/Cas9-medaited knockout of endogenous T-cell receptor in Jurkat cells and generation of NY-ESO-1-specific T cells: An in vitro study.
Safarzadeh Kozani P; Shokrgozar MA; Evazalipour M; Roudkenar MH
Int Immunopharmacol; 2022 Sep; 110():109055. PubMed ID: 35853277
[TBL] [Abstract] [Full Text] [Related]
9. T Cells Engineered to Express Immunoreceptors Targeting the Frequently Expressed Medullary Thyroid cancer Antigens Calcitonin, CEA, and RET M918T.
Erickson TA; Shih YP; Fass J; Jang M; Tran E
Thyroid; 2022 Jul; 32(7):789-798. PubMed ID: 35587601
[No Abstract] [Full Text] [Related]
10. Efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-specific T cell expansion.
Le Gall C; Cammarata A; de Haas L; Ramos-Tomillero I; Cuenca-Escalona J; Schouren K; Wijfjes Z; Becker AMD; Bödder J; Dölen Y; de Vries IJM; Figdor CG; Flórez-Grau G; Verdoes M
J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35428705
[TBL] [Abstract] [Full Text] [Related]
11. Phase I clinical trial evaluating the safety and efficacy of ADP-A2M10 SPEAR T cells in patients with MAGE-A10
Blumenschein GR; Devarakonda S; Johnson M; Moreno V; Gainor J; Edelman MJ; Heymach JV; Govindan R; Bachier C; Doger de Spéville B; Frigault MJ; Olszanski AJ; Lam VK; Hyland N; Navenot JM; Fayngerts S; Wolchinsky Z; Broad R; Batrakou D; Pentony MM; Sanderson JP; Gerry A; Marks D; Bai J; Holdich T; Norry E; Fracasso PM
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35086946
[TBL] [Abstract] [Full Text] [Related]
12. Bioinformatics analysis identified shared differentially expressed genes as potential biomarkers for Hashimoto's thyroiditis-related papillary thyroid cancer.
Liu C; Pan Y; Li Q; Zhang Y
Int J Med Sci; 2021; 18(15):3478-3487. PubMed ID: 34522174
[No Abstract] [Full Text] [Related]
13. Pseudogene Transcripts in head and neck cancer: Literature Review and
Carron J; Della Coletta R; Lourenço GJ
Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440428
[TBL] [Abstract] [Full Text] [Related]
14. cancer incidence among musicians: 45 years of follow-up in four Nordic countries.
Pukkala E; Peltomaa M; Mäkitie A; Heikkinen S; Kjærheim K; Martinsen JI; Sparén P; Tryggvadottir L; Weiderpass E
Acta Oncol; 2021 Jul; 60(7):835-841. PubMed ID: 34162315
[TBL] [Abstract] [Full Text] [Related]
15. Generation of neoantigen-specific T cells for adoptive cell transfer for treating head and neck squamous cell carcinoma.
Wei T; Leisegang M; Xia M; Kiyotani K; Li N; Zeng C; Deng C; Jiang J; Harada M; Agrawal N; Li L; Qi H; Nakamura Y; Ren L
Oncoimmunology; 2021 May; 10(1):1929726. PubMed ID: 34104546
[TBL] [Abstract] [Full Text] [Related]
16. Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery.
Chiou SH; Tseng D; Reuben A; Mallajosyula V; Molina IS; Conley S; Wilhelmy J; McSween AM; Yang X; Nishimiya D; Sinha R; Nabet BY; Wang C; Shrager JB; Berry MF; Backhus L; Lui NS; Wakelee HA; Neal JW; Padda SK; Berry GJ; Delaidelli A; Sorensen PH; Sotillo E; Tran P; Benson JA; Richards R; Labanieh L; Klysz DD; Louis DM; Feldman SA; Diehn M; Weissman IL; Zhang J; Wistuba II; Futreal PA; Heymach JV; Garcia KC; Mackall CL; Davis MM
Immunity; 2021 Mar; 54(3):586-602.e8. PubMed ID: 33691136
[TBL] [Abstract] [Full Text] [Related]
17. Two novel cell culture models of buccal mucosal oral cancer from patients with no risk-habits of tobacco smoking or chewing.
Vipparthi K; Patel AK; Ghosh S; Das S; Das C; Das K; Sarkar A; Thatikonda V; Pal B; Remani ASKN; Arora N; Parihar M; Vijayakumar MV; Bhat MK; Boppana R; Bhattacharjee S; Biswas NK; Arun P; Sharan R; Singh S
Oral Oncol; 2021 Feb; 113():105131. PubMed ID: 33387705
[TBL] [Abstract] [Full Text] [Related]
18. Pan-cancer analysis of genomic properties and clinical outcome associated with tumor tertiary lymphoid structure.
Lin Z; Huang L; Li S; Gu J; Cui X; Zhou Y
Sci Rep; 2020 Dec; 10(1):21530. PubMed ID: 33299035
[TBL] [Abstract] [Full Text] [Related]
19. Phase II Adjuvant cancer-specific Vaccine Therapy for Esophageal cancer Patients Curatively Resected After Preoperative Therapy With Pathologically Positive Nodes; Possible Significance of Tumor Immune Microenvironment in its Clinical Effects.
Yasuda T; Nishiki K; Hiraki Y; Kato H; Iwama M; Shiraishi O; Yasuda A; Shinkai M; Kimura Y; Sukegawa Y; Chiba Y; Imano M; Takeda K; Satou T; Shiozaki H; Nakamura Y
Ann Surg; 2022 Jan; 275(1):e155-e162. PubMed ID: 33055588
[TBL] [Abstract] [Full Text] [Related]
20. Size of Lugol-unstained lesions as a predictor for risk of progression in premalignant lesions of the esophagus.
Liu M; Zhou R; Guo C; Xu R; Liu A; Yang H; Li F; Duan L; Shen L; Wu Q; Liu Z; Liu F; Liu Y; Pan Y; Cai H; Weiss NS; He Z; Ke Y
Gastrointest Endosc; 2021 May; 93(5):1065-1073.e3. PubMed ID: 32950597
[TBL] [Abstract] [Full Text] [Related]
[Next]
